Intuitive Surgical Inc (ISRG)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$411.06
Buy
$412.00
$-1.84 (-0.45%)
Prices updated at 13 Jun 2026, 00:58 EDT
| Prices minimum 15 mins delay
Prices in USD
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci s ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 8,352m | 10,065m | |
| 5,634m | 6,642m | |
| 2,349m | 2,946m | |
| 28.12 | 29.27 | |
| 2,323m | 2,856m | |
| 2,849m | 3,623m | |
| Sales, General and administrative | 2,140m | 2,385m |
| Interest expenses | - | - |
| Provision for income taxes | 336m | 435m |
| Operating expenses | 3,285m | 3,697m |
| Income before taxes | 2,674m | 3,311m |
| Net income available to common shareholders | 2,323m | 2,856m |
| 6.54 | 8 | |
| Net interest income | 325m | 366m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 6.42 | 7.87 |
| Free cash flow per share | 1.625 | 6.2471 |
| Book value/share | 43.6997 | 47.6759 |
| Debt equity ratio | - | - |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 7,111m | 9,780m |
| Current liabilities | 1,745m | 2,006m |
| Total capital | 16,434m | 17,824m |
| Total debt | - | - |
| Total equity | 16,434m | 17,824m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 18,743m | 20,459m |
| Total liabilities | - | - |
| Cash and cash equivalents | 2,027m | 3,368m |
| Common stock | 357m | 355m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 2,770m | 2,062m |
| Cash dividends paid | - | - |
| 1,304m | 2,491m | |
| Investments (gains) losses | -3,273m | 666m |
| 2,062m | 3,407m | |
| Net income | - | - |
| 2,415m | 3,031m | |
| -1,111m | -540m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.